Would you or someone you know like to participate in a research study for an investigational medicine to treat adult Attention-Deficit Hyperactivity Disorder (ADHD)? The MEASURE Study is now recruiting adults who have been diagnosed with ADHD for a clinical trial taking place at 13 doctors’ offices in the U.S. and two in Israel.
As you may know, some patients who are prescribed medications for ADHD either do not respond to these treatments or cannot tolerate them.
The MEASURE Study will examine the effects of the investigational medicine on inattention, impulsivity and hyperactivity in adults with ADHD. This medicine is not a stimulant and works differently than approved ADHD medications, including other non-stimulant drugs.
Are You Eligible?
Adults between the ages of 18 and 55 who have been diagnosed with ADHD may be eligible to participate in this clinical trial. It is open to women (who are not pregnant or breastfeeding) and men who can:
Understand, read, write and speak English fluently
Swallow tablets or capsules
Attend doctors’ appointments regularly and reliably
Participation in the MEASURE Study is completely free and will be conducted in physician offices in the following cities:
San Francisco, California
St. Louis, Missouri
Raleigh, North Carolina
Tel Aviv, Israel
Reasons to Participate
Participating in a clinical research study gives you the opportunity to play an active part in your own healthcare and help others with ADHD. One half of the participants in the MEASURE Study will receive investigational ADHD medicine and the other half will receive a placebo that contains no active ingredients. But all participants will be contributing to research that could lead to better treatments for everyone living with ADHD.